Antifibrotic Activity of Acylated and Unacylated Ghrelin

Fibrosis can affect almost all tissues and organs, it often represents the terminal stage of chronic diseases, and it is regarded as a major health issue for which efficient therapies are needed. Tissue injury, by inducing necrosis/apoptosis, triggers inflammatory response that, in turn, promotes fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Elia Angelino, Simone Reano, Michele Ferrara, Emanuela Agosti, Andrea Graziani, Nicoletta Filigheddu
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2015/385682
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551728470294528
author Elia Angelino
Simone Reano
Michele Ferrara
Emanuela Agosti
Andrea Graziani
Nicoletta Filigheddu
author_facet Elia Angelino
Simone Reano
Michele Ferrara
Emanuela Agosti
Andrea Graziani
Nicoletta Filigheddu
author_sort Elia Angelino
collection DOAJ
description Fibrosis can affect almost all tissues and organs, it often represents the terminal stage of chronic diseases, and it is regarded as a major health issue for which efficient therapies are needed. Tissue injury, by inducing necrosis/apoptosis, triggers inflammatory response that, in turn, promotes fibroblast activation and pathological deposition of extracellular matrix. Acylated and unacylated ghrelin are the main products of the ghrelin gene. The acylated form, through its receptor GHSR-1a, stimulates appetite and growth hormone (GH) release. Although unacylated ghrelin does not bind or activate GHSR-1a, it shares with the acylated form several biological activities. Ghrelin peptides exhibit anti-inflammatory, antioxidative, and antiapoptotic activities, suggesting that they might represent an efficient approach to prevent or reduce fibrosis. The aim of this review is to summarize the available evidence regarding the effects of acylated and unacylated ghrelin on different pathologies and experimental models in which fibrosis is a predominant characteristic.
format Article
id doaj-art-39e656581fa14d888d62e69e16cfa5f4
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-39e656581fa14d888d62e69e16cfa5f42025-02-03T06:00:40ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/385682385682Antifibrotic Activity of Acylated and Unacylated GhrelinElia Angelino0Simone Reano1Michele Ferrara2Emanuela Agosti3Andrea Graziani4Nicoletta Filigheddu5Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, ItalyFibrosis can affect almost all tissues and organs, it often represents the terminal stage of chronic diseases, and it is regarded as a major health issue for which efficient therapies are needed. Tissue injury, by inducing necrosis/apoptosis, triggers inflammatory response that, in turn, promotes fibroblast activation and pathological deposition of extracellular matrix. Acylated and unacylated ghrelin are the main products of the ghrelin gene. The acylated form, through its receptor GHSR-1a, stimulates appetite and growth hormone (GH) release. Although unacylated ghrelin does not bind or activate GHSR-1a, it shares with the acylated form several biological activities. Ghrelin peptides exhibit anti-inflammatory, antioxidative, and antiapoptotic activities, suggesting that they might represent an efficient approach to prevent or reduce fibrosis. The aim of this review is to summarize the available evidence regarding the effects of acylated and unacylated ghrelin on different pathologies and experimental models in which fibrosis is a predominant characteristic.http://dx.doi.org/10.1155/2015/385682
spellingShingle Elia Angelino
Simone Reano
Michele Ferrara
Emanuela Agosti
Andrea Graziani
Nicoletta Filigheddu
Antifibrotic Activity of Acylated and Unacylated Ghrelin
International Journal of Endocrinology
title Antifibrotic Activity of Acylated and Unacylated Ghrelin
title_full Antifibrotic Activity of Acylated and Unacylated Ghrelin
title_fullStr Antifibrotic Activity of Acylated and Unacylated Ghrelin
title_full_unstemmed Antifibrotic Activity of Acylated and Unacylated Ghrelin
title_short Antifibrotic Activity of Acylated and Unacylated Ghrelin
title_sort antifibrotic activity of acylated and unacylated ghrelin
url http://dx.doi.org/10.1155/2015/385682
work_keys_str_mv AT eliaangelino antifibroticactivityofacylatedandunacylatedghrelin
AT simonereano antifibroticactivityofacylatedandunacylatedghrelin
AT micheleferrara antifibroticactivityofacylatedandunacylatedghrelin
AT emanuelaagosti antifibroticactivityofacylatedandunacylatedghrelin
AT andreagraziani antifibroticactivityofacylatedandunacylatedghrelin
AT nicolettafiligheddu antifibroticactivityofacylatedandunacylatedghrelin